Accueil | Fils de syndication
Afficher l'Article
Switching From Tamoxifen to Exemestane in Estrogen-Receptor-Positive Breast Cancer
Onsdag den 11. Apr 2007 - kl. 09:00 - 1 År, 9 måneder depuis - Presse spécialisée - Medscape family medicine
Disease free survival rate improved, but difference in overall survival unknown. Gynecologic complications reduced, but osteoporosis and fractures increased. Journal Watch






